This paper by Marius Zeeb and colleagues describes the creation of the Swiss HIV Cohort Study Viral Next Generation Sequencing Database (SHCND), an important new research resource embedded within the Swiss HIV Cohort Study (SHCS). In this work, Marius Zeeb, as first author, helped describe and present how this database was designed, set up, and used to organize and analyze large amounts of HIV genetic sequencing data in a reliable and reproducible way.
The paper shows very clearly how important the SHCS is. This resource was only possible because the SHCS has followed large numbers of people with HIV over many years and has linked clinical data with biological samples. Together with the Zurich Primary HIV Infection Cohort Study, it has enrolled 21’876 people with HIV since 1988, with a biobank going back to the early 1990s. This makes it possible to connect viral genetic information with treatment history, drug resistance, disease course, and other clinical outcomes.
Since its start in 2018, the database has already collected sequencing data from 5’178 unique people with HIV, making it a major national platform for HIV research in Switzerland. It has already supported studies on HIV drug resistance, superinfection, time since infection, viral evolution, and neurocognitive symptoms.
This does not mean that patient care changes immediately. But this kind of work could help improve clinical care in the future. More detailed viral sequencing may eventually support more precise resistance testing, better treatment decisions, and a deeper understanding of how HIV behaves over time. The authors also note that this system could later be adapted not only for research, but potentially for clinical, diagnostic, and surveillance use.
Overall, this paper shows that the SHCS is an essential foundation for modern HIV research in Switzerland. Its long-term follow-up, biobank, and national collaboration make this kind of innovation possible. The immediate impact is better research infrastructure; the longer-term hope is that this will contribute to better and more personalized HIV care in the future.